Koa Shoji Holdings Co.,Ltd. (TYO:9273)

Market Cap	33.69B +18.5%
Revenue (ttm)	23.98B +4.4%
Net Income	3.73B +2.4%
EPS	88.58 +1.2%
Shares Out	42.12M
PE Ratio	9.03
Forward PE	n/a
Dividend	18.00 (2.22%)
Ex-Dividend Date	Jun 29, 2026

Volume	184,400
Open	806.00
Previous Close	811.00
Day's Range	796.00 - 811.00
52-Week Range	666.00 - 919.00
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	May 11, 2026

About Koa Shoji Holdings

Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. The company is involved in the manufacture and marketing of over-the-counter drugs and pharmacologically active injection. It also engages in contract manufacturing of pharmaceuticals; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 304
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9273

Financial Performance

In fiscal year 2025, Koa Shoji Holdings's revenue was 23.27 billion, an increase of 5.13% compared to the previous year's 22.13 billion. Earnings were 3.64 billion, an increase of 23.46%.